tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMNN Stock Latest News

Imunon showcases progress on IMNN-001 at R&D Day
The FlyImunon showcases progress on IMNN-001 at R&D Day
17h ago
IMNN
Imunon to present Phase 3 OVATION 3 study of IMNN-001
PremiumThe Fly
Imunon to present Phase 3 OVATION 3 study of IMNN-001
12d ago
IMNN
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
PremiumCompany Announcements
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
14d ago
IMNN
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
PremiumCompany Announcements
Imunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian Cancer
14d ago
IMNN
Imunon to present Phase 3 OVATION trial of IMNN-001
PremiumThe Fly
Imunon to present Phase 3 OVATION trial of IMNN-001
28d ago
IMNN
Imunon: OVATION 2 study results reinforce IMNN-001 efficacy benefits
PremiumThe FlyImunon: OVATION 2 study results reinforce IMNN-001 efficacy benefits
2M ago
IMNN
Imunon to present translational data from Phase 2 OVATION 2 Study of IMNN-001
Premium
The Fly
Imunon to present translational data from Phase 2 OVATION 2 Study of IMNN-001
2M ago
IMNN
Imunon Regains Nasdaq Compliance with Bid Price Requirement
Premium
Company Announcements
Imunon Regains Nasdaq Compliance with Bid Price Requirement
2M ago
8K
IMNN
Imunon regains compliance with Nasdaq min bid price listing requirement
PremiumThe Fly
Imunon regains compliance with Nasdaq min bid price listing requirement
2M ago
IMNN
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
PremiumCompany Announcements
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
3M ago
IMNN
Imunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany Announcements
Imunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment?
3M ago
IMNN
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment?
PremiumCompany Announcements
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment?
3M ago
IMNN
Imunon, Inc. Advances Cancer Treatment with Phase 3 Trial of IMNN-001
PremiumCompany AnnouncementsImunon, Inc. Advances Cancer Treatment with Phase 3 Trial of IMNN-001
3M ago
IMNN
IMUNON, Inc. Reports Progress in Cancer Therapy
Premium
Company Announcements
IMUNON, Inc. Reports Progress in Cancer Therapy
3M ago
IMNN
Imunon, Inc. Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Imunon, Inc. Earnings Call Highlights Progress and Challenges
3M ago
IMNN
Imunon sees cash runway into 4Q25
PremiumThe Fly
Imunon sees cash runway into 4Q25
3M ago
IMNN
Imunon reports Q2 EPS ($2.15), consensus ($4.99)
PremiumThe Fly
Imunon reports Q2 EPS ($2.15), consensus ($4.99)
3M ago
IMNN
IMNN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IMNN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
IMNN
Imunon announces first patient dosed in Phase 3 OVATION 3 study of IMNN-001
PremiumThe Fly
Imunon announces first patient dosed in Phase 3 OVATION 3 study of IMNN-001
3M ago
IMNN
Imunon Announces 15% Stock Dividend Approval
PremiumCompany AnnouncementsImunon Announces 15% Stock Dividend Approval
4M ago
8K
IMNN
Imunon board approves 15% stock dividend
Premium
The Fly
Imunon board approves 15% stock dividend
4M ago
IMNN
Imunon, Inc. Advances DNA Vaccine Study for COVID-19 Variants
Premium
Company Announcements
Imunon, Inc. Advances DNA Vaccine Study for COVID-19 Variants
4M ago
IMNN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >